# Starling Oncology, Inc.: Form DEF 14A, filed Mar 27, 2025

- Company: [Starling Oncology, Inc.](/companies/stln.md) (CIK 1799191)
- Form: DEF 14A
- Filed: 2025-03-27
- Accepted by EDGAR: Mar 27, 2025, 06:05 ET
- Period: 2025-05-07
- Accession: 0001193125-25-064588
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1799191/000119312525064588/d836146ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799191/000119312525064588/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799191/000119312525064588/d836146ddef14a.htm

Filed Mar 27, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-064588. Last ingested by Listed: Nov 15, 2026, 04:34 ET. No prices; not investment advice.
